Authors:
Hurenkamp, GJB
Grundmeijer, HGLM
Van der Ende, A
Tytgat, GNJ
Assendelft, WJJ
Van der Hulst, RWM
Citation: Gjb. Hurenkamp et al., Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study, ALIM PHARM, 15(7), 2001, pp. 1047-1054
Authors:
Hurenkamp, GJB
van der Ende, A
Grundmeijer, HGLM
Tytgat, GNJ
Van der Hulst, RWM
Citation: Gjb. Hurenkamp et al., Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease, ALIM PHARM, 14(8), 2000, pp. 1065-1070
Authors:
Van der Hulst, RWM
Lamouliatte, H
Megraud, F
Pounder, RE
Stoltes, M
Vaira, D
Williams, M
Tytgat, GNJ
Citation: Rwm. Van Der Hulst et al., Laser assisted ratio analyser C-13-urea breath testing, for the detection of H-pylori: a prospective diagnostic European multicentre study, ALIM PHARM, 13(9), 1999, pp. 1171-1177
Authors:
Houben, MHMG
Hensen, EF
Rauws, EAJ
Van der Hulst, RWM
Van't Hoff, BWM
Van der Ende, A
Ten Kate, FJW
Tytgat, GNJ
Citation: Mhmg. Houben et al., Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains, ALIM PHARM, 13(7), 1999, pp. 883-889